HDAC7 and B-cell non-Hodgkin lymphoma: The modulation of HDAC7 expression in specific types of B-ALL and B-cell lymphoma leading to the induction of apoptosis and the downregulation of the c-Myc oncogene may be a promising therapeutic pathway in future.